Clinical Trials · NCT02384122
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radboud University Medical Center
- Enrollment
- 62
- Start date
- Sep 2015
- Locations
- 12 sites, Netherlands
- Primary endpoint
- Difference in blood and parenteral iron requirements (transfusion units)